How a 50,000-Square-Meter Smart Manufacturing Powerhouse is Shaping the Future of B2B Supply ChainsDriven by strict MDR CE, FDA, and NMPA compliances, Globalipl's fully operational industrial park is empowering distributors and clinics across 180+ countries.
By: globalipl As a 23-year market veteran, Globalipl Development Co., Ltd. has solved this challenge by transitioning from traditional manufacturing to large-scale intelligent fabrication at its Globalipl (Dezhou) Medical Aesthetic Industrial Park. Representing a landmark corporate investment of RMB 500 million (~$70M USD), this massive 50,000-square- 1. Unmatched Production Scale & Vertical Integration Unlike fragmented OEM workshops, the fully active industrial park features semi-automated precision assembly lines and dust-free optical laboratories.
2. Rigorous Global Regulatory Compliance Navigating strict medical regulations is seamless with Globalipl. The entire infrastructure operates under the ISO 13485 Medical Devices Quality Management System, and the product spectrum holds top-tier international clearances:
This uncompromising compliance ensures friction-free customs clearance and direct alignment with local health authorities worldwide. 3. Advanced R&D and Strategic Western Alliances Globalipl drives innovation through Academic-Industrial Research partnerships with prestigious universities and strategic technological alliances with top-tier German optical engineering firms. This synergy fuses Western optical precision with Globalipl's proprietary software and core algorithms. Today, this scientific devotion is backed by a robust intellectual property portfolio of 87 core patents (including utility models, design patents, and software copyrights). 4. Comprehensive Technology Portfolio Globalipl offers 8 major series of advanced aesthetic modalities designed for high-yield clinical returns:
End
|
|